Review of genotoxicity and rat carcinogenicity investigations with astaxanthin

This publication has 29 references indexed in Scilit:

• Safety assessment of [3S, 3′S]-astaxanthin – Subchronic toxicity study in rats
  Food and Chemical Toxicology, 2015
• Selection of appropriate tumour data sets for Benchmark Dose Modelling (BMD) and derivation of a Margin of Exposure (MoE) for substances that are genotoxic and carcinogenic: Considerations of biological relevance of tumour type, data quality and uncertainty assessment
  Food and Chemical Toxicology, 2014
• Scientific Opinion on the safety of astaxanthin-rich ingredients (AstaREAL A1010 and AstaREAL L10) as novel food ingredients
  EFSA Journal, 2014
• Scientific Opinion on the safety and efficacy of astaxanthin (CAROPHYLL® Pink 10% CWS) for salmonids and ornamental fish
  EFSA Journal, 2014
• Hepatocytes Polyploidization and Cell Cycle Control in Liver Physiopathology
  International Journal of Hepatology, 2012
• Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin
  FEMS Immunology & Medical Microbiology, 2007
• IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans
  Critical Reviews in Toxicology, 2006
• Prediction of Rodent Carcinogenesis: An Evaluation of Prechronic Liver Lesions as Forecasters of Liver Tumors in NTP Carcinogenicity Studies
  Toxicologic Pathology, 2004
• Effects of provitamin a or non‐provitamin a carotenoids on liver xenobiotic‐metabolizing enzymes in mice
  Nutrition and Cancer, 1997
• Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat
  Xenobiotica, 1996